QQ客服 官方微博 反馈留言

	A multicenter, randomized, controlled, phase Ⅲ clinical study of PEG-rhG-CSF for preventing chemotherapy-induced neutropenia in patients with breast cancer and non-small cell lung cancer].
	Xu Binghe; Tian Fuguo; Yu Jingrui; Song Yanqiu; Shi Jianhua; Zhang Baihong; Zhang Yanjun; Yuan Zhiping; Wu Qiong; Zhang Qingyuan
刊名	Zhonghua zhong liu za zhi [Chinese journal of oncology]
	2016
卷号	38页码:23-7
ISSN号	0253-3766
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2954840
专题	西安交通大学
推荐引用方式 GB/T 7714	Xu Binghe,Tian Fuguo,Yu Jingrui,et al. A multicenter, randomized, controlled, phase Ⅲ clinical study of PEG-rhG-CSF for preventing chemotherapy-induced neutropenia in patients with breast cancer and non-small cell lung cancer].[J]. Zhonghua zhong liu za zhi [Chinese journal of oncology],2016,38:23-7.
APA	Xu Binghe.,Tian Fuguo.,Yu Jingrui.,Song Yanqiu.,Shi Jianhua.,...&Chen Lin.(2016).A multicenter, randomized, controlled, phase Ⅲ clinical study of PEG-rhG-CSF for preventing chemotherapy-induced neutropenia in patients with breast cancer and non-small cell lung cancer]..Zhonghua zhong liu za zhi [Chinese journal of oncology],38,23-7.
MLA	Xu Binghe,et al."A multicenter, randomized, controlled, phase Ⅲ clinical study of PEG-rhG-CSF for preventing chemotherapy-induced neutropenia in patients with breast cancer and non-small cell lung cancer].".Zhonghua zhong liu za zhi [Chinese journal of oncology] 38(2016):23-7.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。